• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Etiological Factors and Visual Outcomes of Dense Vitreous Hemorrhage in Patients Aged 80 years and above over the Past Decade in a Tertiary General Hospital.一家三级综合医院过去十年中80岁及以上患者致密性玻璃体积血的病因及视力预后
J Ophthalmol. 2023 Sep 28;2023:8851207. doi: 10.1155/2023/8851207. eCollection 2023.
2
Prognosis value of Chinese Ocular Fundus Diseases Society classification for proliferative diabetic retinopathy on postoperative visual acuity after pars plana vitrectomy in type 2 diabetes.中国眼底病学组增殖性糖尿病视网膜病变分类对2型糖尿病患者玻璃体切割术后视力的预后价值
Int J Ophthalmol. 2022 Oct 18;15(10):1627-1633. doi: 10.18240/ijo.2022.10.10. eCollection 2022.
3
[Pars plana vitrectomy, phacoemulsification and intraocular lens implantation for the management of cataract and proliferative diabetic retinopathy: comparison of a combined versus two-step surgical approach].[玻璃体切割联合白内障超声乳化吸除及人工晶状体植入术治疗白内障合并增殖性糖尿病视网膜病变:联合手术与两步手术方法的比较]
Arch Soc Esp Oftalmol. 2009 Jan;84(1):31-8. doi: 10.4321/s0365-66912009000100005.
4
Visual Recovery and Prognosis in the Treatment of Submacular Hemorrhage due to Polypoidal Choroidal Vasculopathy and Retinal Arterial Macroaneurysm: A Retrospective Study.息肉样脉络膜血管病变和视网膜动脉大动脉瘤导致的黄斑下出血的治疗中视力恢复和预后:一项回顾性研究。
Int J Clin Pract. 2023 Jun 12;2023:3880297. doi: 10.1155/2023/3880297. eCollection 2023.
5
THE INCIDENCE, CHARACTERISTICS, MANAGEMENT, PROGNOSIS, AND CLASSIFICATION OF BREAKTHROUGH VITREOUS HEMORRHAGE SECONDARY TO POLYPOIDAL CHOROIDAL VASCULOPATHY.息肉样脉络膜血管病变继发玻璃体积血的发生率、特征、处理、预后和分类。
Retina. 2021 Aug 1;41(8):1675-1685. doi: 10.1097/IAE.0000000000003098.
6
Visual outcomes of vitrectomy for polypoidal choroidal vasculopathy-related breakthrough vitreous haemorrhage.息肉样脉络膜血管病变相关的玻璃体出血性突破行玻璃体切除术后的视觉效果。
Eye (Lond). 2014 Jul;28(7):797-806; quiz 807. doi: 10.1038/eye.2014.124. Epub 2014 Jun 13.
7
Surgical outcomes of vitrectomy for breakthrough vitreous hemorrhage in eyes with exudative age-related macular degeneration.增生型年龄相关性黄斑变性患眼玻璃体积血穿破行玻璃体切割术的手术效果。
Int Ophthalmol. 2021 May;41(5):1835-1844. doi: 10.1007/s10792-021-01744-x. Epub 2021 Feb 21.
8
Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy.评价增生型糖尿病视网膜病变行玻璃体切割术联合术前玻璃体内注射雷珠单抗和术后玻璃体内注射曲安奈德的效果。
Int Ophthalmol. 2021 May;41(5):1635-1642. doi: 10.1007/s10792-021-01703-6. Epub 2021 Feb 4.
9
[Minimally invasive vitrectomy for the treatment of severe proliferative diabetic retinopathy].微创玻璃体切除术治疗重度增殖性糖尿病视网膜病变
Zhonghua Yan Ke Za Zhi. 2021 Jun 11;57(6):440-446. doi: 10.3760/cma.j.cn112142-20200812-00538.
10
Outcomes of Pars Plana Vitrectomy with Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy Without Retinal Detachment: A Seven-Year Retrospective Study.不伴有视网膜脱离的增生性糖尿病视网膜病变行玻璃体切割联合全视网膜光凝术的疗效:一项七年回顾性研究
Clin Ophthalmol. 2023 Feb 1;17:471-478. doi: 10.2147/OPTH.S400474. eCollection 2023.

本文引用的文献

1
Long-Term Mortality and Bone Safety in Patients with End-Stage Renal Disease Receiving Lanthanum Carbonate.接受碳酸镧治疗的终末期肾病患者的长期死亡率和骨骼安全性。
Nephron. 2018;140(4):265-274. doi: 10.1159/000492603. Epub 2018 Oct 23.
2
Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.眼内组织型纤溶酶原激活物、雷珠单抗联合气体注射治疗息肉样脉络膜血管病变伴黄斑下出血
Ophthalmology. 2016 Jun;123(6):1278-86. doi: 10.1016/j.ophtha.2016.01.035. Epub 2016 Mar 2.
3
Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization.眼内抗血管内皮生长因子治疗脉络膜新生血管性黄斑下出血。
Ophthalmology. 2014 Apr;121(4):926-35. doi: 10.1016/j.ophtha.2013.11.004. Epub 2013 Dec 15.
4
Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature.视网膜分支静脉阻塞:流行病学、发病机制、危险因素、临床特征、诊断和并发症。文献更新。
Retina. 2013 May;33(5):901-10. doi: 10.1097/IAE.0b013e3182870c15.
5
Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy.病变大小与息肉样脉络膜血管病变的视觉预后的关系。
Am J Ophthalmol. 2011 Jun;151(6):961-972.e1. doi: 10.1016/j.ajo.2011.01.002. Epub 2011 Mar 31.
6
Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test.“手动”和“数指”视力可通过 Freiburg 视力测试进行量化。
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1236-40. doi: 10.1167/iovs.05-0981.
7
Secondary acute angle-closure glaucoma associated with vitreous hemorrhage after ruptured retinal arterial macroaneurysm.视网膜动脉大动脉瘤破裂后玻璃体出血相关的继发性急性闭角型青光眼。
Am J Ophthalmol. 2004 Oct;138(4):682-3. doi: 10.1016/j.ajo.2004.05.027.
8
Retinopathy in diabetes.糖尿病性视网膜病变
Diabetes Care. 2004 Jan;27 Suppl 1:S84-7. doi: 10.2337/diacare.27.2007.s84.
9
Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics.息肉样脉络膜血管病变:发病率、人口统计学特征及临床特点
Arch Ophthalmol. 2003 Oct;121(10):1392-6. doi: 10.1001/archopht.121.10.1392.
10
Muscle strength before and mortality after a bone fracture in older people.
Scand J Med Sci Sports. 2002 Oct;12(5):296-300. doi: 10.1034/j.1600-0838.2002.102100.x.

一家三级综合医院过去十年中80岁及以上患者致密性玻璃体积血的病因及视力预后

Etiological Factors and Visual Outcomes of Dense Vitreous Hemorrhage in Patients Aged 80 years and above over the Past Decade in a Tertiary General Hospital.

作者信息

Ding Yuhua, Yao Bangtao, Ye Hui, Wang Fei

机构信息

Department of Ophthalmology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

Department of Ophthalmology, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, Jiangsu, China.

出版信息

J Ophthalmol. 2023 Sep 28;2023:8851207. doi: 10.1155/2023/8851207. eCollection 2023.

DOI:10.1155/2023/8851207
PMID:37811536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10555502/
Abstract

This study aimed to investigate the main etiological factors and visual outcomes in patients with dense vitreous hemorrhage (DVH) aged ≥80 years. We retrospectively included patients with DVH aged ≥80 years who were admitted to our ophthalmology department between January 1, 2010, and December 31, 2019. All patients underwent pars plana vitrectomy (PPV). Data regarding demographic characteristics; preoperative and postoperative best-corrected visual acuity (BCVA), intraocular pressure (IOP), and ophthalmic B-scan ultrasonography findings; intraoperative conditions; and postoperative complications were collected and analyzed. A total of 44 patients (44 eyes) were enrolled, with a median age of 82 years; among them, 25 patients (56.82%) were men. The median preoperative BCVA was 2.3 (1.1-3.0). The main etiological factors included retinal vein occlusion (RVO) (20 eyes, 45.45%), polypoidal choroidal vasculopathy (PCV) (15 eyes, 34.09%), proliferative diabetic retinopathy (PDR) (7 eyes, 15.90%), retinal arterial macroaneurysm (RAM) (1 eye, 2.27%), and posterior vitreous detachment (PVD) (1 eye, 2.27%). The median final BCVA was 1.92 (0.5-2.6). There was a significant postoperative improvement in the BCVA; moreover, branch RVO (BRVO) had a better postoperative visual prognosis than central RVO (CRVO), PCV, and PDR ( < 0.05). The final postoperative BCVA was significantly better when the initial BCVA was above hand motion (HM) than when it was HM or lower ( < 0.05). Our findings indicate that RVO, PCV, and PDR were the main causes of DVH. Microinvasive PPV is a safe and effective method that can clarify diagnosis and improve BCVA. Patients with BRVO and preoperative BCVA > HM may have a relatively good visual prognosis. For patients aged ≥80 years who have an appropriate general condition, PPV can be timely performed to treat DVH.

摘要

本研究旨在调查年龄≥80岁的致密性玻璃体出血(DVH)患者的主要病因及视力预后。我们回顾性纳入了2010年1月1日至2019年12月31日期间在我院眼科住院的年龄≥80岁的DVH患者。所有患者均接受了玻璃体切割术(PPV)。收集并分析了患者的人口统计学特征、术前和术后最佳矫正视力(BCVA)、眼压(IOP)、眼科B超检查结果、术中情况及术后并发症等数据。共纳入44例患者(44只眼),中位年龄为82岁;其中男性25例(56.82%)。术前BCVA中位数为2.3(1.1 - 3.0)。主要病因包括视网膜静脉阻塞(RVO)(20只眼,45.45%)、息肉样脉络膜血管病变(PCV)(15只眼,34.09%)、增殖性糖尿病视网膜病变(PDR)(7只眼,15.90%)、视网膜动脉大动脉瘤(RAM)(1只眼,2.27%)和玻璃体后脱离(PVD)(1只眼,2.27%)。最终BCVA中位数为1.92(0.5 - 2.6)。术后BCVA有显著改善;此外,分支RVO(BRVO)的术后视力预后优于中央RVO(CRVO)、PCV和PDR(P < 0.05)。初始BCVA高于手动(HM)时的最终术后BCVA明显优于初始BCVA为HM或更低时(P < 0.05)。我们的研究结果表明,RVO、PCV和PDR是DVH的主要原因。微创PPV是一种安全有效的方法,可明确诊断并改善BCVA。BRVO且术前BCVA > HM的患者可能有相对较好的视力预后。对于年龄≥80岁且全身状况适宜的患者,可及时进行PPV治疗DVH。